↓
 

Tag Archives: Memorial Sloan-Kettering

Dr. Samyukta Mullangi, on Paths to Improving on the Current Dysfunctional System of State-Based Medical Licensing to Work with Current Practice Needs | BTJ-013

Hosts Jack West and Charu Aggarwal discuss with Dr. Samyukta Mullangi of Memorial Sloan-Kettering the limitations of the current state-based medical licensing requirements and several potential paths to adapt to telemedicine & current practice needs. (36:02)

Audio Podcast

Dr. Fumiko Chino (Pt 2): Studying and Raising Awareness of Financial Toxicity in Cancer Care

Host Dr. Jack West speaks with Dr. Fumiko Chino, radiation oncologist at Memorial Sloan-Kettering and caregiver to a young spouse who died of cancer, about the under-appreciated but severe and shame-inducing impact of cost and financial toxicity among families of patients with cancer. (25:44)

Dr. Fumiko Chino (Pt 1): The Challenges of Serving as a Caregiver to a Young Spouse with Cancer

Dr. Fumiko Chino, radiation oncologist at Memorial Sloan-Kettering Cancer Center, describes to host Jack West the impact of a mother as a successful radiation oncologist, & the many struggles of serving as a caregiver to a young adult spouse with cancer. (29:22)

Dr. Greg Riely (Pt 2): Should local ablation therapy in oligometastatic or oligoprogressing cancer be incorporated into routine practice?

Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice. (28:11)

Dr. Greg Riely (Pt 1): Current Practice & Challenges in Execution of Genomic Testing in Lung Cancer Treatment

Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center (MSKCC) chats with Dr. Jack West about current standards in molecular testing for advanced NSCLC & potential challenges in execution in translating the promise of genomics into broad practice. (19:57)

How do Patients with Advanced NSCLC on Daily Steroids Do on Immune Checkpoint Inhibitors? (BMIC-046)

Dr. Jack West summarizes findings of a retrospective analysis from Dr. Arbour of MSKCC, evaluating the clinical outcomes of patients with advanced NSCLC on daily steroids while receiving an immune checkpoint inhibitor against PD-1 or PD-L1. (9:06)

Download MP3 Audio Version

↑